SMi's Master Class hosted by Buntinx PharmaNeuroSciences will discuss on how a 'Payer Centric Approach' can drive Future CNS Clinical Development and how innovative techniques and superiority concepts - validated by in depth market access evaluation - can lead to successful new CNS therapeutics BENEFITS OF ATTENDING • Get an insight in the real drivers of the future CNS clinical development programs and related opportunities • Learn how 'Superiority' is the new objective for future CNS clinical development • Identify the key driving factors for having a real chance on the CNS market place, dominated by the payers • Work with your peers on how new techniques and concepts can creat a major opportunity in the main CNS domains: Depression, Schizophrenia and Alzheimers Disease